UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapy

British journal of cancer, 2014-11, Vol.111 (11), p.2103-2113

2014

Volltextzugriff (PDF)

Fibroblast Growth Factors and Their Receptors in Urological Cancers: Basic Research and Clinical Implications

European urology, 2003-03, Vol.43 (3), p.309-319

2003

Volltextzugriff (PDF)

Effects of WNT/beta-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines

International journal of oncology, 2005-04, Vol.26 (4), p.1033

2005

Volltextzugriff (PDF)

Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression

Oncogene, 2007-03, Vol.26 (13), p.1875-1884

2007

Volltextzugriff (PDF)

Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor

Cancer research (Chicago, Ill.), 1994-10, Vol.54 (20), p.5474-5478

1994

Volltextzugriff (PDF)

Molecular biology of prostate cancer

Molecular human reproduction, 2003-08, Vol.9 (8), p.437-448

2003

Volltextzugriff (PDF)

The androgen receptor in hormone-refractory prostate cancer: relevance of different mechanisms of androgen receptor signaling (Review)

International journal of oncology, 2003-10, Vol.23 (4), p.1095

2003

Volltextzugriff (PDF)

Regulation of prostatic growth and function by peptide growth factors

The Prostate, 1996-06, Vol.28 (6), p.392-405

1996

Volltextzugriff (PDF)

Mutant androgen receptor detected in a advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone

Molecular endocrinology (Baltimore, Md.), 1993-12, Vol.7 (12), p.1541-1550

1993

Volltextzugriff (PDF)

[11C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy

World journal of urology, 2009-10, Vol.27 (5), p.619-625

2009

Volltextzugriff (PDF)

Molecular aspects of prostate cancer

World journal of urology, 2012-06, Vol.30 (3), p.277-278

2012

Volltextzugriff (PDF)

Transforming growth factor-β in benign and malignant prostate

The Prostate, 1999-06, Vol.39 (4), p.285-290

1999

Volltextzugriff (PDF)

Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells

British journal of cancer, 2000-01, Vol.82 (1), p.39-45

2000

Volltextzugriff (PDF)

Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines

Oncogene, 2004-04, Vol.23 (20), p.3541-3549

2004

Volltextzugriff (PDF)

Basic Fibroblast Growth Factor Synthesis by Human Peritoneal Mesothelial Cells : Induction by Interleukin-1

The American journal of pathology, 1999-12, Vol.155 (6), p.1977-1984

1999

Volltextzugriff (PDF)

Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate

The Prostate, 1997-06, Vol.31 (4), p.223-233

1997

Volltextzugriff (PDF)

Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markers

The Prostate, 1997-02, Vol.30 (2), p.117-129

1997

Volltextzugriff (PDF)

Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas

British journal of cancer, 1997-01, Vol.75 (12), p.1753-1760

1997

Volltextzugriff (PDF)

Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells

The Prostate, 1997-07, Vol.32 (2), p.106-114

1997

Volltextzugriff (PDF)

Interleukin 1β mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells

British journal of cancer, 1998-10, Vol.78 (8), p.1004-1011

1998

Volltextzugriff (PDF)

Bedeutung der Androgenrezeptor-Spleißvariante AR-V7 für Prognose und Therapie des fortgeschrittenen Prostatakarzinoms

Aktuelle Urologie, 2020-12, Vol.51 (6), p.582-592

2020

Volltextzugriff (PDF)

DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction

The Prostate, 1993, Vol.22 (1), p.11-22

1993

Volltextzugriff (PDF)

Activation of the androgen receptor by polypeptide growth factors and cellular regulators

World journal of urology, 1995-10, Vol.13 (5), p.285-289

1995

Volltextzugriff (PDF)

Nuclear localization and DNA binding of ecdysone receptor and ultraspiracle

Archives of insect biochemistry and physiology, 2007-07, Vol.65 (3), p.125-133

2007

Volltextzugriff (PDF)

Androgen receptor gene mutations in prostate cancer : Implications for disease progression and therapy

Drugs & aging, 1997, Vol.10 (1), p.50-58

1997

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(59)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapy

Fibroblast Growth Factors and Their Receptors in Urological Cancers: Basic Research and Clinical Implications

Effects of WNT/beta-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines

Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression

Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor

Molecular biology of prostate cancer

The androgen receptor in hormone-refractory prostate cancer: relevance of different mechanisms of androgen receptor signaling (Review)

Regulation of prostatic growth and function by peptide growth factors

Mutant androgen receptor detected in a advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone

[11C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy

Molecular aspects of prostate cancer

Transforming growth factor-β in benign and malignant prostate

Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells

Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines

Basic Fibroblast Growth Factor Synthesis by Human Peritoneal Mesothelial Cells : Induction by Interleukin-1

Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate

Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markers

Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas

Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells

Interleukin 1β mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells

Bedeutung der Androgenrezeptor-Spleißvariante AR-V7 für Prognose und Therapie des fortgeschrittenen Prostatakarzinoms

DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction

Activation of the androgen receptor by polypeptide growth factors and cellular regulators

Nuclear localization and DNA binding of ecdysone receptor and ultraspiracle

Androgen receptor gene mutations in prostate cancer : Implications for disease progression and therapy

Suchergebnisse filtern